Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis
Gasdermin D (GSDMD) and gasdermin E (GSDME) perpetuate inflammation by mediating the release of cytokines such as interleukin-1β (IL-1β) and IL-18. However, not only are the actions of GSDMD in colitis still controversial, but its interplay with GSDME in the pathogenesis of this disease has not been...
Main Authors: | Jianqiu Xiao, Kai Sun, Chun Wang, Yousef Abu-Amer, Gabriel Mbalaviele |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909022000235 |
Similar Items
-
Disulfiram ameliorates ischemia/reperfusion-induced acute kidney injury by suppressing the caspase-11-GSDMD pathway
by: Qiaoting Cai, et al.
Published: (2022-12-01) -
Icaritin Exerts Anti-Cancer Effects through Modulating Pyroptosis and Immune Activities in Hepatocellular Carcinoma
by: Yuanyuan Jiao, et al.
Published: (2024-08-01) -
Disulfiram alleviates acute lung injury and related intestinal mucosal barrier impairment by targeting GSDMD-dependent pyroptosis
by: Jiping Zhao, et al.
Published: (2022-10-01) -
O-GlcNAcylation dictates pyroptosis
by: Yue Lang, et al.
Published: (2024-12-01) -
Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases
by: Xueming Xu, et al.
Published: (2024-06-01)